NDUFA13 Antikörper
Kurzübersicht für NDUFA13 Antikörper (ABIN7116705)
Target
Alle NDUFA13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- NDUFA13 antibody
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- NADH dehydrogenase(ubiquinone) 1 alpha subcomplex, 13
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:2000, IP: 1:200-1:1000, IHC: 1:20-1:200, IF: 1:20-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months
-
Haltbarkeit
- 12 months
-
-
- NDUFA13 (NADH Dehydrogenase (Ubiquinone) 1 alpha Subcomplex, 13 (NDUFA13))
-
Andere Bezeichnung
- NDUFA13
-
Hintergrund
- NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13|Cell death regulatory protein GRIM-19|Complex I-B16.6 (CI-B16.6)|Gene associated with retinoic and interferon-induced mortality 19 protein (GRIM-19, Gene associated with retinoic and IFN-induced mortality 19 protein)|NADH-ubiquinone oxidoreductase B16.6 subunit|NDUFA13|GRIM19
-
Molekulargewicht
- 16.5 kDa
-
UniProt
- Q9P0J0
-
Pathways
- Protein targeting to Nucleus, Negative Regulation of intrinsic apoptotic Signaling
Target
-